Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.02 USD | -5.98% | -7.81% | +18.30% |
05-02 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
05-02 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.30% | 3.39B | |
+3.71% | 106B | |
+7.02% | 23.47B | |
-14.68% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.52% | 16.78B | |
+5.18% | 14.41B | |
+35.72% | 12.86B | |
+325.79% | 8.78B |
- Stock Market
- Equities
- SWTX Stock
- News SpringWorks Therapeutics, Inc.
- Transcript : SpringWorks Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07